BioLife Historical Cash Flow

Stocks . USA . 
Stock . BioLife Solutions
BLFS Stock  USD 27.06  0.29  1.08%   
Analysis of BioLife Solutions cash flow over time is an excellent tool to project BioLife Solutions future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Change In Cash of 16.8 M or Change In Working Capital of 1.5 M as it is a great indicator of BioLife Solutions ability to facilitate future growth, repay debt on time or pay out dividends.
   Cash Flow   Balance Sheet   Income Statement
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining BioLife Solutions latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether BioLife Solutions is a good buy for the upcoming year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioLife Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.
For more information on how to buy BioLife Stock please use our How to Invest in BioLife Solutions guide.

About BioLife Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in BioLife balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which BioLife's non-liquid assets can be easily converted into cash.
Balance Sheet
Statement
Details
Profit & Loss
Statement
Details
Financial
Indicators
Details
Valuation
Indicators
Details

BioLife Solutions Cash Flow Chart

At this time, BioLife Solutions' End Period Cash Flow is comparatively stable compared to the past year. Change To Account Receivables is likely to gain to about 16.1 M in 2024, despite the fact that Total Cash From Operating Activities is likely to grow to (11.9 M).
Begin Period Cash Flow  Total Cash From Financing Activities  End Period Cash Flow  Total Cashflows From Investing Activities  Stock Based Compensation  Cash And Cash Equivalents Changes  
Add Fundamental

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Total Cashflows From Investing Activities

The net amount of cash used in or generated from a company's investment activities, such as purchasing or selling assets, during a reporting period.

Stock Based Compensation

Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.
Most accounts from BioLife Solutions' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into BioLife Solutions current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioLife Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.
For more information on how to buy BioLife Stock please use our How to Invest in BioLife Solutions guide.At this time, BioLife Solutions' End Period Cash Flow is comparatively stable compared to the past year. Change To Account Receivables is likely to gain to about 16.1 M in 2024, despite the fact that Total Cash From Operating Activities is likely to grow to (11.9 M).

BioLife Solutions cash flow statement Correlations

Sale Purchase Of Stock
Change In Cash
Free Cash Flow
Change In Working Capital
Begin Period Cash Flow
Depreciation
Other Non Cash Items
Capital Expenditures
Net Income
End Period Cash Flow
Change To Inventory
Change To Account Receivables
Change To Liabilities
Stock Based Compensation
Change Receivables
Net Borrowings
Cash And Cash Equivalents Changes
Cash Flows Other Operating
Change To Netincome
Investments
Change To Operating Activities
Issuance Of Capital Stock
Sale Purchase Of Stock
0.15-0.77-0.260.610.930.390.92-0.650.75-0.680.25-0.07-0.04-0.76-0.80.970.310.72-0.440.82-0.08
Change In Cash
0.150.350.51-0.51-0.21-0.53-0.180.40.520.130.37-0.27-0.05-0.220.190.220.27-0.140.23-0.090.45
Free Cash Flow
-0.770.350.31-0.61-0.89-0.55-0.840.83-0.250.77-0.290.08-0.020.490.73-0.74-0.3-0.830.31-0.750.53
Change In Working Capital
-0.260.510.31-0.67-0.48-0.87-0.550.62-0.140.260.620.040.060.420.38-0.250.15-0.230.83-0.190.0
Begin Period Cash Flow
0.61-0.51-0.61-0.670.790.540.81-0.530.47-0.33-0.410.4-0.05-0.58-0.730.56-0.050.31-0.540.75-0.2
Depreciation
0.93-0.21-0.89-0.480.790.610.98-0.820.56-0.740.110.03-0.03-0.74-0.890.90.230.78-0.540.84-0.27
Other Non Cash Items
0.39-0.53-0.55-0.870.540.610.64-0.89-0.01-0.5-0.33-0.180.02-0.36-0.480.380.10.55-0.860.27-0.26
Capital Expenditures
0.92-0.18-0.84-0.550.810.980.64-0.780.62-0.63-0.030.05-0.06-0.75-0.830.90.290.68-0.620.84-0.24
Net Income
-0.650.40.830.62-0.53-0.82-0.89-0.78-0.10.8-0.10.26-0.030.480.67-0.63-0.21-0.860.66-0.470.37
End Period Cash Flow
0.750.52-0.25-0.140.470.56-0.010.62-0.1-0.19-0.030.12-0.1-0.79-0.530.780.230.16-0.290.650.27
Change To Inventory
-0.680.130.770.26-0.33-0.74-0.5-0.630.8-0.19-0.570.330.010.520.68-0.640.07-0.970.21-0.380.11
Change To Account Receivables
0.250.37-0.290.62-0.410.11-0.33-0.03-0.1-0.03-0.57-0.38-0.05-0.01-0.120.240.030.560.530.02-0.03
Change To Liabilities
-0.07-0.270.080.040.40.03-0.180.050.260.120.33-0.380.29-0.03-0.31-0.050.01-0.330.050.34-0.2
Stock Based Compensation
-0.04-0.05-0.020.06-0.05-0.030.02-0.06-0.03-0.10.01-0.050.290.06-0.08-0.030.120.03-0.060.02-0.11
Change Receivables
-0.76-0.220.490.42-0.58-0.74-0.36-0.750.48-0.790.52-0.01-0.030.060.75-0.84-0.25-0.490.48-0.690.04
Net Borrowings
-0.80.190.730.38-0.73-0.89-0.48-0.830.67-0.530.68-0.12-0.31-0.080.75-0.81-0.18-0.70.43-0.810.3
Cash And Cash Equivalents Changes
0.970.22-0.74-0.250.560.90.380.9-0.630.78-0.640.24-0.05-0.03-0.84-0.810.450.69-0.450.85-0.19
Cash Flows Other Operating
0.310.27-0.30.15-0.050.230.10.29-0.210.230.070.030.010.12-0.25-0.180.450.14-0.260.49-0.64
Change To Netincome
0.72-0.14-0.83-0.230.310.780.550.68-0.860.16-0.970.56-0.330.03-0.49-0.70.690.14-0.290.46-0.28
Investments
-0.440.230.310.83-0.54-0.54-0.86-0.620.66-0.290.210.530.05-0.060.480.43-0.45-0.26-0.29-0.340.08
Change To Operating Activities
0.82-0.09-0.75-0.190.750.840.270.84-0.470.65-0.380.020.340.02-0.69-0.810.850.490.46-0.34-0.47
Issuance Of Capital Stock
-0.080.450.530.0-0.2-0.27-0.26-0.240.370.270.11-0.03-0.2-0.110.040.3-0.19-0.64-0.280.08-0.47
Click cells to compare fundamentals

BioLife Solutions Account Relationship Matchups

High Positive Relationship

Capital Expenditures
+ 0.98
Depreciation
Cash And Cash Equivalents Changes
+ 0.97
Sale Purchase Of Stock
Depreciation
+ 0.93
Sale Purchase Of Stock
Capital Expenditures
+ 0.92
Sale Purchase Of Stock
Cash And Cash Equivalents Changes
+ 0.9
Depreciation
Cash And Cash Equivalents Changes
+ 0.9
Capital Expenditures

High Negative Relationship

Change To Netincome
- 0.97
Change To Inventory
Net Income
- 0.89
Other Non Cash Items
Net Borrowings
- 0.89
Depreciation
Depreciation
- 0.89
Free Cash Flow
Other Non Cash Items
- 0.87
Change In Working Capital
Change To Netincome
- 0.86
Net Income

BioLife Solutions cash flow statement Accounts

201920202021202220232024 (projected)
Sale Purchase Of Stock3.9M(4.3M)1.8M101.6M116.9M122.7M
Change In Cash(24.2M)84.0M(20.6M)(50.4M)16.0M16.8M
Free Cash Flow538K1.9M(13.2M)(18.9M)(18.9M)(17.9M)
Change In Working Capital(4.5M)(1.8M)(3.5M)(14.9M)1.5M1.5M
Begin Period Cash Flow30.7M6.4M90.5M69.9M19.5M20.4M
Other Cashflows From Financing Activities(159K)973K116K(1.5M)845K1.3M
Depreciation1.8M5.1M12.9M16.5M12.3M12.9M
Other Non Cash Items4.0M(2.1M)(364K)109.7M8.6M9.0M
Capital Expenditures675K4.6M8.4M10.4M6.4M6.7M
Total Cash From Operating Activities1.2M6.5M(4.8M)(8.5M)(12.5M)(11.9M)
Net Income(1.7M)2.7M(7.6M)(139.8M)(66.4M)(63.1M)
Total Cash From Financing Activities1.6M101.2M(2.8M)16.3M10.6M7.0M
End Period Cash Flow6.4M90.5M69.9M19.5M35.4M37.2M
Change To Inventory(3.8M)(629K)114K(6.6M)(8.6M)(8.1M)
Change To Account Receivables(290K)(1.8M)(10.1M)(10.8M)15.4M16.1M
Change To Liabilities466.5K486K441K(171K)2.0M0.0
Total Cashflows From Investing Activities(27.0M)(23.7M)(12.6M)(58.1M)(52.3M)(49.7M)
Other Cashflows From Investing Activities1.3M(23.7M)(12.6M)(58.1M)(52.3M)(49.7M)
Stock Based Compensation3.0M6.0M14.0M25.3M31.7M18.7M
Change Receivables172.3K(2.0M)(290K)(1.8M)(1.6M)(1.5M)
Net Borrowings979.8K(56K)984K(2.9M)(2.6M)(2.5M)
Cash And Cash Equivalents Changes5.3M24.0M(24.2M)84.0M96.6M101.4M
Cash Flows Other Operating(113.0K)(120K)(10.3M)1.1M1.0M1.1M
Change To Netincome15.0M(1.2M)(9.0M)114.8M132.0M138.6M
Investments1M(23.7M)(12.6M)(58.1M)(1.0M)(1.1M)
Change To Operating Activities(1.2M)805K4.5M2.0M2.3M2.4M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for BioLife Stock Analysis

When running BioLife Solutions' price analysis, check to measure BioLife Solutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLife Solutions is operating at the current time. Most of BioLife Solutions' value examination focuses on studying past and present price action to predict the probability of BioLife Solutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLife Solutions' price. Additionally, you may evaluate how the addition of BioLife Solutions to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY